UMIN000048381

Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy and adverse effect of Janus kinase inhibitor in rheumatoid arthritis.

Department of Hospital Pharmacy, Hamamatsu University School of Medicine·University Hospital Medical Information NetworkNot yet recruiting
Study focus
Disease/Condition
Rheumatoid arthritis
Study type
Observational
Sponsor & location
Primary sponsor
Department of Hospital Pharmacy, Hamamatsu University School of Medicine
Location
Japan
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2022
End date
N/A
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
Registry
University Hospital Medical Information Network
Trial ID
UMIN000048381
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for UMIN000048381 through Pure Global AI's free database. This phase not specified trial is sponsored by Department of Hospital Pharmacy, Hamamatsu University School of Medicine and is currently Not yet recruiting. The study focuses on Rheumatoid arthritis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.